BridgeMD
Compares treatment options for Vitiligo
Official title Effectiveness of Micro-needling With 5 Fluorouracil Versus Potent Topical Steroids in the Treatment of Limited Vitiligo
ClinicalTrials.gov ID: NCT07398807
What this study is testing
What is Microneedling with 5-fluorouracil?
Microneedling with 5-fluorouracil is an investigational medicine, given as an once-weekly treatment applied to the skin, being studied as a potential treatment for vitiligo.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this clinical trial is to learn how well 5 fluorouracil (5FU) with micro-needling works to treat limited vitiligo as compared to strong steroid applied on skin. It will also learn about the safety of both these treatments.
- Phase 1: an early, usually small safety study
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 4 to 70
You may be able to join if
- Patients willing to participate in the study
- Patients of age group of 05 -70 years.
- Vitiligo involving less than or equal to 10% body surface area.
You likely can't join if
- Patients using or have used other treatments for vitiligo
- Pregnant women or lactating women
- Patients with unstable vitiligo
- Patients on immunosuppressant medications due to other diseases
- Patients having anemia, immunosuppression, bleeding disorder, taking anticoagulants or anti-platelet drugs or having epilepsy
- Patient having history of keloids or hypertrophic scars
See the full eligibility criteria
- Patients willing to participate in the study
- Patients of age group of 05 -70 years.
- Vitiligo involving less than or equal to 10% body surface area.
- Patients using or have used other treatments for vitiligo
- Pregnant women or lactating women
- Patients with unstable vitiligo
- Patients on immunosuppressant medications due to other diseases
- Patients having anemia, immunosuppression, bleeding disorder, taking anticoagulants or anti-platelet drugs or having epilepsy
- Patient having history of keloids or hypertrophic scars
- Patients with history of hypersensitivity to either of the drugs
The study team makes the final eligibility decision.
Where it's taking place
- Chak Four Hundred Fifty-four, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 4 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chak Four Hundred Fifty-four, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.